Partial-edentulism — Prevalence of Partial Edentulism Among Patients of Faculty of Dentistry Cairo University
Citation(s)
1 Muneeb, A., Khan, B. M., & Jamil, B. (2013). Causes and pattern of partial edentulism/exodontia and its association with age and gender: semi rural population, Baqai Dental college, Karachi, Pakistan. International Dental Journal of students research, 1, 13-18. 2.Sapkota, B., Adhikari, B., & Upadhaya, C. (2013). A Study of Assessment of Partial edentulous patients based on Kennedy's classification at Dhulikhel Hospital Kathmandu University Hospital. Kathmandu University Medical Journal, 11(4), 325-327. 3. Bharathi, M., Babu, K. R., Reddy, G., Gupta, N., Misuriya, A., & Vinod, V. (2014). Partial Edentulism based on Kennedy's classifcation: an epidemiological study. The journal of contemporary dental practice, 15(2), 229- 231. 4. Madhankumar, S., Mohamed, K., Natarajan, S., Kumar, V. A., Athiban, I., & Padmanabhan, T. V. (2015). Prevalence of partial edentulousness among the patients reporting to the Department of Prosthodontics Sri Ramachandra University Chennai, India: An epidemiological study. Journal of pharmacy & bioallied sciences, 7(Suppl 2), S643. 5. Nayyer, M., Khan, D. A., Gul, H., Aslam, A., Khan, N. B., & Aslam, F. (2020). Patterns of partial edentulism according to kennedy's classification-a cross sectional study. Pakistan Armed Forces Medical Journal, 70(Suppl-1), S87-90. 6. World Health Organization. Oral Health Surveys: Basic Methods, 4th ed. Geneva: WHO; 2014.
Prevalence of Partial Edentulism Among Patients of Faculty of Dentistry Cairo University
Interventional studies are often prospective and are specifically tailored to evaluate direct impacts of treatment or preventive measures on disease.
Observational studies are often retrospective and are used to assess potential causation in exposure-outcome relationships and therefore influence preventive methods.
Expanded access is a means by which manufacturers make investigational new drugs available, under certain circumstances, to treat a patient(s) with a serious disease or condition who cannot participate in a controlled clinical trial.
Clinical trials are conducted in a series of steps, called phases - each phase is designed to answer a separate research question.
Phase 1: Researchers test a new drug or treatment in a small group of people for the first time to evaluate its safety, determine a safe dosage range, and identify side effects.
Phase 2: The drug or treatment is given to a larger group of people to see if it is effective and to further evaluate its safety.
Phase 3: The drug or treatment is given to large groups of people to confirm its effectiveness, monitor side effects, compare it to commonly used treatments, and collect information that will allow the drug or treatment to be used safely.
Phase 4: Studies are done after the drug or treatment has been marketed to gather information on the drug's effect in various populations and any side effects associated with long-term use.
